Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

Conditions: Acute Myeloid Leukemia (AML); High-risk Myelodysplastic Syndrome Interventions: Drug: RVU120 Sponsors: Ryvu Therapeutics SA Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials